These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15252854)

  • 1. Extensive analysis of the 7q31 region in human prostate tumors supports TES as the best candidate tumor suppressor gene.
    Chêne L; Giroud C; Desgrandchamps F; Boccon-Gibod L; Cussenot O; Berthon P; Latil A
    Int J Cancer; 2004 Sep; 111(5):798-804. PubMed ID: 15252854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extensive analysis of D7S486 in primary gastric cancer supports TESTIN as a candidate tumor suppressor gene.
    Ma H; Weng D; Chen Y; Huang W; Pan K; Wang H; Sun J; Wang Q; Zhou Z; Wang H; Xia J
    Mol Cancer; 2010 Jul; 9():190. PubMed ID: 20626849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extensive analysis of the 13q14 region in human prostate tumors: DNA analysis and quantitative expression of genes lying in the interval of deletion.
    Latil A; Chêne L; Mangin P; Fournier G; Berthon P; Cussenot O
    Prostate; 2003 Sep; 57(1):39-50. PubMed ID: 12886522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Minimal commonly deleted regions on chromosome 7q31 in primary gastric carcinoma and its clinical significance].
    Li JT; Fu L; Xia JC; Feng BJ; Mai SJ; Yu XJ; Huang LX; Feng QS; Pan ZZ; Zhan YQ
    Ai Zheng; 2005 Nov; 24(11):1306-11. PubMed ID: 16552953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The TES gene at 7q31.1 is methylated in tumours and encodes a novel growth-suppressing LIM domain protein.
    Tobias ES; Hurlstone AF; MacKenzie E; McFarlane R; Black DM
    Oncogene; 2001 May; 20(22):2844-53. PubMed ID: 11420696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers.
    Gunduz M; Ouchida M; Fukushima K; Ito S; Jitsumori Y; Nakashima T; Nagai N; Nishizaki K; Shimizu K
    Oncogene; 2002 Jun; 21(28):4462-70. PubMed ID: 12080476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer.
    Latil A; Cussenot O; Fournier G; Baron JC; Lidereau R
    Clin Cancer Res; 1995 Nov; 1(11):1385-9. PubMed ID: 9815935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity at 7q31.1 and 12p13-12 in advanced prostate cancer.
    Kawana Y; Ichikawa T; Suzuki H; Ueda T; Komiya A; Ichikawa Y; Furuya Y; Akakura K; Igarashi T; Ito H
    Prostate; 2002 Sep; 53(1):60-4. PubMed ID: 12210480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity in human primary prostate carcinomas: a possible tumor suppressor gene at 7q31.1.
    Zenklusen JC; Thompson JC; Troncoso P; Kagan J; Conti CJ
    Cancer Res; 1994 Dec; 54(24):6370-3. PubMed ID: 7987830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression and clinical significance of TESTIN in primary gastric cancer].
    Huang W; Weng DS; Pan ZZ; Pan K; Ding PR; Zhou J; Wang H; Zhang HK; Li JJ; Xia JC
    Ai Zheng; 2008 Sep; 27(9):984-8. PubMed ID: 18799041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational and functional analyses reveal that ST7 is a highly conserved tumor-suppressor gene on human chromosome 7q31.
    Zenklusen JC; Conti CJ; Green ED
    Nat Genet; 2001 Apr; 27(4):392-8. PubMed ID: 11279520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An LOH and mutational investigation of the ST7 gene locus in human esophageal carcinoma.
    Wang S; Mori Y; Sato F; Yin J; Xu Y; Zou TT; Olaru A; Kimos MC; Perry K; Selaru FM; Deacu E; Sun M; Shi YC; Shibata D; Abraham JM; Greenwald BD; Meltzer SJ
    Oncogene; 2003 Jan; 22(3):467-70. PubMed ID: 12545169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHC1-L, a candidate gene for prostate carcinogenesis at 13q14.2, is frequently affected by loss of heterozygosity and underexpressed in human prostate cancer.
    Latil A; Morant P; Fournier G; Mangin P; Berthon P; Cussenot O
    Int J Cancer; 2002 Jun; 99(5):689-96. PubMed ID: 12115502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity analysis of a candidate gastric carcinoma tumor suppressor locus at 7q31.
    Xia JC; Weng DS; Li JT; Qin HD; Mai SJ; Feng BJ; Fan Q; Feng QS; Huang LX; Yu XJ; Pan ZZ; Li YQ; Wang QJ; Zhan YQ; Chen SP; He J; Huang WL; Wu PH; Zeng YX
    Cancer Genet Cytogenet; 2006 Apr; 166(2):166-72. PubMed ID: 16631475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definitive functional evidence for a tumor suppressor gene on human chromosome 7q31.1 neighboring the Fra7G site.
    Zenklusen JC; Hodges LC; LaCava M; Green ED; Conti CJ
    Oncogene; 2000 Mar; 19(13):1729-33. PubMed ID: 10763831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A molecular cytogenetic analysis of 7q31 in prostate cancer.
    Jenkins RB; Qian J; Lee HK; Huang H; Hirasawa K; Bostwick DG; Proffitt J; Wilber K; Lieber MM; Liu W; Smith DI
    Cancer Res; 1998 Feb; 58(4):759-66. PubMed ID: 9485032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression.
    Takahashi S; Shan AL; Ritland SR; Delacey KA; Bostwick DG; Lieber MM; Thibodeau SN; Jenkins RB
    Cancer Res; 1995 Sep; 55(18):4114-9. PubMed ID: 7664288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression changes of CAV1 and EZH2, located on 7q31 approximately q36, are rarely related to genomic alterations in primary prostate carcinoma.
    Bachmann N; Haeusler J; Luedeke M; Kuefer R; Perner S; Assum G; Paiss T; Hoegel J; Vogel W; Maier C
    Cancer Genet Cytogenet; 2008 Apr; 182(2):103-10. PubMed ID: 18406871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent loss of heterozygosity in human primary squamous cell and colon carcinomas at 7q31.1: evidence for a broad range tumor suppressor gene.
    Zenklusen JC; Thompson JC; Klein-Szanto AJ; Conti CJ
    Cancer Res; 1995 Mar; 55(6):1347-50. PubMed ID: 7882334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent hypermethylation and loss of heterozygosity of the testis derived transcript gene in ovarian cancer.
    Qiu H; Zhu J; Yuan C; Yan S; Yang Q; Kong B
    Cancer Sci; 2010 May; 101(5):1255-60. PubMed ID: 20180808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.